On August 9, the National Health and Medical Commission issued the “Notice on Including Azvudine Tablets in the Novel Coronavirus Pneumonia Diagnosis and Treatment Program”. The full text is as follows:
On August 9, the National Health and Medical Commission issued the “Notice on Including Azvudine Tablets in the Novel Coronavirus Pneumonia Diagnosis and Treatment Program”. The full text is as follows: